Paclitaxel-Loaded Macrophage Membrane Camouflaged Albumin Nanoparticles for Targeted Cancer Therapy

Paclitaxel-Loaded Macrophage Membrane Camouflaged Albumin Nanoparticles for Targeted Cancer Therapy

Xi Cao,1,2 Tingfei Tan,1,2 Dongchun Zhu,1,2 Haixia Yu,1,2 Yaru Liu,1,2 Haiyun Zhou,1,2 Yong Jin,3,4 Quan Xia1,2 1Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China; 2The Grade 3 Pharmaceutical Chemistry Laboratory of State A...

Full description

Bibliographic Details
Main Authors:	Cao X, Tan T, Zhu D, Yu H, Liu Y, Zhou H, Jin Y, Xia Q
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-03-01
Series:	International Journal of Nanomedicine
Subjects:	macrophage membrane albumin nanoparticles melanoma paclitaxel tumor-targeted therapy
Online Access:	https://www.dovepress.com/paclitaxel-loaded-macrophage-membrane-camouflaged-albumin-nanoparticle-peer-reviewed-article-IJN

Similar Items

Evaluation of nanoparticle albumin-bound paclitaxel loaded macrophages for glioblastoma treatment based on a microfluidic chip
by: Zuorun Xie, et al.
Published: (2024-03-01)

Nanoparticle albumin-bound paclitaxel – first step of nanotechnology into clinical practice
by: R. N. Alyautdin, et al.
Published: (2022-06-01)

Evaluate the Clinical Outcome of Nanoparticle Albumin-bound Paclitaxel on Breast Cancer Treatment: A Systematic Review and Meta-analysis
by: Yasaman Shariati, et al.
Published: (2022-09-01)

Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models
by: Hang Chen, et al.
Published: (2021-01-01)

Tolerance, Variability and Pharmacokinetics of Albumin-Bound Paclitaxel in Chinese Breast Cancer Patients
by: Qingmei Li, et al.
Published: (2018-11-01)

A case report of hypocalcemia after chemotherapy with albumin‐bound paclitaxel
by: Zhongchao Wang, et al.
Published: (2023-03-01)

Nanoparticle Albumin-Bound Paclitaxel- and/or Gemcitabine-Induced Scleroderma Accompanied by Acanthosis Nigricans-Like Skin Changes
by: Sei-ichiro Motegi, et al.
Published: (2019-10-01)

Ultra-widefield angiographic imaging of albumin-bound paclitaxel-induced cystoid macular edema
by: Junhyuck Lee, et al.
Published: (2019-01-01)

Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo
by: Deng W, et al.
Published: (2018-01-01)

Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein
by: Wenwen Xu, et al.
Published: (2023-11-01)

Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation
by: Dongdong Li, et al.
Published: (2018-01-01)

Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma
by: Zhichao Tian, et al.
Published: (2020-07-01)

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
by: Jincheng Yang, et al.
Published: (2018-01-01)

Cystoid Macular Edema following Treatment with Nanoparticle Albumin-Bound Paclitaxel and Atezolizumab for Metastatic Breast Cancer
by: Hiroaki Yamane, et al.
Published: (2023-10-01)

Macrophage membrane-camouflaged pH-sensitive nanoparticles for targeted therapy of oral squamous cell carcinoma
by: Lin Yang, et al.
Published: (2024-04-01)

VE-Albumin Core-Shell Nanoparticles for Paclitaxel Delivery to Treat MDR Breast Cancer
by: Bo Tang, et al.
Published: (2018-10-01)

Albumin-Bound Paclitaxel: Worthy of Further Study in Sarcomas
by: Zhichao Tian, et al.
Published: (2022-02-01)

Paclitaxel-loaded star-shaped copolymer nanoparticles for enhanced malignant melanoma chemotherapy against multidrug resistance
by: Su Y, et al.
Published: (2017-03-01)

Carfilzomib and Paclitaxel Co-Loaded Protein Nanoparticles an Effective Therapy Against Pancreatic Adenocarcinomas
by: Cheng WT, et al.
Published: (2021-10-01)

Paclitaxel-Loaded Folate-Targeted Albumin-Alginate Nanoparticles Crosslinked with Ethylenediamine. Synthesis and In Vitro Characterization
by: Ana María Martínez-Relimpio, et al.
Published: (2021-06-01)

Efficacy and safety of albumin-bound paclitaxel combined with gemcitabine in the treatment of advanced and metastatic pancreatic cancer
by: TIAN Yue, et al.
Published: (2023-09-01)

Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer
by: Tiantian Tan, et al.
Published: (2023-07-01)

The efficacy and safety of nanoparticle albumin bound‐paclitaxel‐based regimen as second‐ or third‐line treatment in patients with advanced esophageal squamous cell carcinoma
by: Dao Xin, et al.
Published: (2023-05-01)

Intravitreal Ranibizumab Had Limited Effect on Cystoid Macular Edema Due to Albumin-Bound Paclitaxel: A Case Report and Literature Review
by: Suna Ye, et al.
Published: (2021-12-01)

Efficacy and safety of sintilimab plus albumin-bound-paclitaxel in recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase II trialResearch in context
by: Yin Wang, et al.
Published: (2023-11-01)

Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer
by: Huan Wang, et al.
Published: (2022-06-01)

Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy
by: Yaqin Tu, et al.
Published: (2023-12-01)

Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy
by: Pandya AD, et al.
Published: (2019-08-01)

Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis
by: Shanqiang Qu, et al.
Published: (2023-10-01)

Clinical Research on Albumin-bound Paclitaxel-based Therapy in Advanced Lung Cancer
by: Xu LI, et al.
Published: (2017-06-01)

Paclitaxel-Loaded Nanosponges Inhibit Growth and Angiogenesis in Melanoma Cell Models
by: Nausicaa Clemente, et al.
Published: (2019-07-01)

Exceptional Response to Nanoparticle Albumin-Bound Paclitaxel and Gemcitabine in a Patient with a Refractory Adenocarcinoma of the Ampulla of Vater
by: Markus Kapp, et al.
Published: (2016-01-01)

In situ administration of temperature-sensitive hydrogel composite loading paclitaxel microspheres and cisplatin for the treatment of melanoma
by: Yanlin Liu, et al.
Published: (2023-04-01)

Lipid-albumin nanoassemblies co-loaded with borneol and paclitaxel for intracellular drug delivery to C6 glioma cells with P-gp inhibition and its tumor targeting
by: Bo Tang, et al.
Published: (2015-10-01)

Macular Cystoid Edema Induced by Nab-Paclitaxel
by: Sara Alves Pereira, et al.
Published: (2022-04-01)

Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis
by: Miao Liu, et al.
Published: (2021-02-01)

Human Albumin Fragments Nanoparticles as PTX Carrier for Improved Anti-cancer Efficacy
by: Liang Ge, et al.
Published: (2018-06-01)

The targeting imaging and treatment capacity of gelsolin-targeted and paclitaxel-loaded PLGA nanoparticles in vitro and in vivo
by: Jiamei Ji, et al.
Published: (2022-10-01)

Harnessing PD-1 cell membrane-coated paclitaxel dimer nanoparticles for potentiated chemoimmunotherapy
by: Nannan Hu, et al.
Published: (2024-05-01)

Phase I study of cisplatin and nanoparticle albumin‐bound‐paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma
by: Hui Jiang, et al.
Published: (2023-07-01)